Sitravatinib: Additional Phase I data

Data from 52 patients with advanced solid tumors in an open-label, dose-escalation, U.S. Phase I/Ib

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE